Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,06 USD | +1,98% | +10,75% | +14,44% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 51,12 mln. 47,81 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -53 mln. -49,57 mln. | Nettowinst (verlies) 2025 * | -74 mln. -69,21 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,42
x | K/w-verhouding 2025 * |
-2,29
x | Werknemers | 20 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,57% |
Recentste transcriptie over Eledon Pharmaceuticals, Inc.
1 dag | +1,98% | ||
1 week | +10,75% | ||
1 maand | -2,83% | ||
3 maanden | +13,19% | ||
6 maanden | +38,26% | ||
Lopend jaar | +14,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 01-05-20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 15-03-21 |
Steven N. Perrin
PSD | President | 59 | 14-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 01-05-17 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 14-09-20 |
John S. McBride
BRD | Director/Board Member | 72 | 01-05-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2,06 | +1,98% | 81 544 |
25-04-24 | 2,02 | +2,54% | 67 382 |
24-04-24 | 1,97 | -8,80% | 100 805 |
23-04-24 | 2,16 | +6,93% | 190 023 |
22-04-24 | 2,02 | +8,60% | 313 628 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,44% | 51,12 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |